Pharma manufacturer Adwia will invest EGP 400 mn this year to add new production lines and make upgrades at its 10th of Ramadan factory, Al Borsa quoted company head Mohamed Khattab as saying. The company is also planning to take 11 new products to market this year, and to tap new export markets.

About Adwia: A pan–African pharma investment fund launched by the European Bank for Reconstruction and Development, the UK’s CDC Group, and Development Partners International acquired 99.6% of the drugmaker for USD 126 mn in late 2020. The company produces more than 100 meds for the Egyptian market, and exports its products to several Arab and African countries, according to Al Borsa.